Un nouveau traitement dans le psoriasis du cuir chevelu : Carte d'identité Xamiol® et résultats à 8 semaines

The development of a new formulation associating calcipotriol 50 μg/g and betamethasone 0.5 mg/g in gel form opens new perspectives in the treatment of scalp psoriasis. The efficacy and tolerance of Xamiol® gel were evaluated in the international multicenter, randomized, placebo-controlled (four groups) MBL0405 study with assessment at 8 weeks. This study demonstrated that the calcipotriol/betamethasone gel (Xamiol® gel) is a rapidly effective treatment, is well tolerated, and has no notable side effects. It provides therapeutic autonomy to patients and should take an important place in the treatment of scalp psoriasis.